BioSpace News Archive

The global Ceftriaxone Sodium market size is estimated to be worth US$ 264.2 million in 2021 and is forecast to a readjusted size of US$ 217.6 million by 2030 with a CAGR of -2.7% during the forecast period 2022-2030.

According to Nova one advisor, the U.S. Fundus Camera market size was valued at US$ 130.16 Million in 2021 and is expected to hit US$ 191.80 Million by 2030, growing at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030.

The U.S. Cardiac Resynchronization Therapy market size was valued at US$ 983.3 Million in 2021 and is expected to hit US$ 1.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, has completed patient enrollment in its clinical study evaluating an “extra-strength” dose for extended duration of Jeuveau® (prabotulinumtoxinA-xvfs), its flagship neurotoxin product and the first and only neurotoxin dedicated exclusively to aesthetics.

AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), announced today their publication in collaboration with researchers at Arizona State University (ASU) entitled, “Third COVID-19 Vaccine Dose Boosts Neutralizing Antibodies in Poor Responders” in Communications Medicine, part of the Nature family of journals.

NeuroOne Medical Technologies Corporation today announced the first clinical case using the Evo sEEG electrode was performed by Dr. Robert Gross at Emory University.

Ultima Genomics, Inc. (the Company) has signed an agreement with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to further advance Ultima Genomics’ sequencing architecture.

Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that CEO and Co-Founder Mr. James Nathanielsz, BAS, MEI, believes the Company’s lead asset could unlock value as PRP advances to a Phase I, First-In-Human study in advanced cancer patients.

Varex Imaging Corporation announced that it will report unaudited financial results for the third quarter of fiscal year 2022 following the close of regular trading on Tuesday, August 2, 2022.

The global artificial intelligence in healthcare market is expected to reach a market size of USD 215.53 Billion by 2030 and register a substantially high CAGR over the forecast period, according to a new report by Reports and Data